Halo Labs Raises $12M in Series B1 Financing Round and Enters into the FDA Market

By WebmasterApril 6, 2020November 1st, 2024No Comments

Halo Labs Raises $12M in Series B1 Financing Round and Enters into the FDA Market

Previous PostWellsheet Used by Physicians at Concord Hospital Battling COVID-19 Outbreak
Next PostOssianix is responding to the COVID-19 pandemic by developing therapeutic single domain VNAR antibodies to the COVID-19 spike protein.